Search research articles
Contact Us
Filters
Showing results (51-60 of 101) with videos related to
Page
of 11
Sort By:
Hypertension (Dallas, Tex. : 1979)
|
June 18, 1999
Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort
K M O'Shaughnessy, B Fu, F Ferraro, et al.
JAMA Internal Medicine
|
May 7, 2014
Descriptions and interpretations of the ACCORD-Lipid trial in the news and biomedical literature: a cross-sectional analysis
Nicholas S Downing, Theresa Cheng, Harlan M Krumholz, et al.
Pharmacoepidemiology and Drug Safety
|
November 12, 2015
Regulatory anticipation of postmarket safety problems for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study
Jean-David Zeitoun, Jérémie H Lefèvre, Nicholas S Downing, et al.
The New England Journal of Medicine
|
November 1, 2018
Complements from the Lung
Nicholas S Downing, Ciaran J McMullan, Helmut G Rennke, et al.
Water Environment Research : a Research Publication of the Water Environment Federation
|
April 8, 2010
Nitrogen removal from wastewater using a hybrid membrane-biofilm process: pilot-scale studies
Leon S Downing, Kyle J Bibby, Kathleen Esposito, et al.
JAMA
|
January 23, 2014
Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012
Nicholas S Downing, Jenerius A Aminawung, Nilay D Shah, et al.
Expert Opinion on Drug Safety
|
December 8, 2017
New and incremental FDA black box warnings from 2008 to 2015
Michael T Solotke, Sanket S Dhruva, Nicholas S Downing, et al.
Surgical Forum
|
January 1, 1976
An experimental model of cardiomyopathy
H Riahi, S O Burman, T Casale, et al.
JAMA
|
July 29, 2015
Mortality, Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013
Harlan M Krumholz, Sudhakar V Nuti, Nicholas S Downing, et al.
JAMA Network Open
|
June 10, 2021
Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019
Meera Dhodapkar, Audrey D Zhang, Jeremy Puthumana, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 101) with videos related to
Sort By:
Page
of 11
Hypertension (Dallas, Tex. : 1979)
|
June 18, 1999
Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort
K M O'Shaughnessy, B Fu, F Ferraro, et al.
JAMA Internal Medicine
|
May 7, 2014
Descriptions and interpretations of the ACCORD-Lipid trial in the news and biomedical literature: a cross-sectional analysis
Nicholas S Downing, Theresa Cheng, Harlan M Krumholz, et al.
Pharmacoepidemiology and Drug Safety
|
November 12, 2015
Regulatory anticipation of postmarket safety problems for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study
Jean-David Zeitoun, Jérémie H Lefèvre, Nicholas S Downing, et al.
The New England Journal of Medicine
|
November 1, 2018
Complements from the Lung
Nicholas S Downing, Ciaran J McMullan, Helmut G Rennke, et al.
Water Environment Research : a Research Publication of the Water Environment Federation
|
April 8, 2010
Nitrogen removal from wastewater using a hybrid membrane-biofilm process: pilot-scale studies
Leon S Downing, Kyle J Bibby, Kathleen Esposito, et al.
JAMA
|
January 23, 2014
Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012
Nicholas S Downing, Jenerius A Aminawung, Nilay D Shah, et al.
Expert Opinion on Drug Safety
|
December 8, 2017
New and incremental FDA black box warnings from 2008 to 2015
Michael T Solotke, Sanket S Dhruva, Nicholas S Downing, et al.
Surgical Forum
|
January 1, 1976
An experimental model of cardiomyopathy
H Riahi, S O Burman, T Casale, et al.
JAMA
|
July 29, 2015
Mortality, Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013
Harlan M Krumholz, Sudhakar V Nuti, Nicholas S Downing, et al.
JAMA Network Open
|
June 10, 2021
Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019
Meera Dhodapkar, Audrey D Zhang, Jeremy Puthumana, et al.
Page
of 11